Respective balance between Gi- and Gs-dependent signalling pathways and their roles in the modification of FcARI-mediated mast cell degranulation
The respective balance between Gi- and Gs-dependent signalling pathways and their roles in the modification of FcαRI-mediated mast cell degranulation. For clarity, many of the intermediary steps in the FcαRI-dependent signalling pathway have been omitted. For further details concerning this pathway and the pathways regulating cytokine production and eicosanoid release, the readers are referred to the text and references [, ]. FcαRI aggregation leads to the phospholipase Cγ (PLCγ)-mediated production of diaclglycerol (DAG) and inositol trisphosphate (IP3) which respectively activate protein kinase C (PKC) and mobilize calcium from intracellular stores, essential signals for degranulation. Phosphoinositide 3-kinase (PI3K), primarily the p110δ subunit, contributes to a maintained calcium signal partly through the Bruton’s tyrosine kinase (Btk)-dependent enhancement of PLCγ activation. Gi-coupled receptors impact these events positively by downregulating the production of cyclic adenosine monophosphate (cAMP) which is a negative signal for mast cell activation and by promoting the activation of PI3Kγ and PLCβ. In contrast Gs-coupled receptors impact FcεRI-mediated mast cell activation by enhancing the production of cAMP which, via activation of protein kinase A (PKA), inhibits mast cell activation by an, as yet, unknown mechanism. S1P2 and P2Y which are coupled to Gq-to induce calcium flux and result in degranulation (not shown in this figure). The green lines and positive symbols designate activating signalling pathways and the red lines and -symbols represent inhibiting signalling pathways.
Publication
G Protein-coupled receptors and the modification of FcεRI-mediated mast cell activation. () Hye Sun Kuehn, et al. Immunol Lett. ;113(2):59-69. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | LPA | LPA | ncbigene_symbol | LPA | 4018 |
| Homo sapiens | Primates | 1and/or3 | OR3 | famplex_relations | OR3A1 | 4994 |
| Homo sapiens | Primates | 1and/or3 | OR3 | famplex_relations | OR3A2 | 4995 |
| Homo sapiens | Primates | 1and/or3 | OR3 | famplex_relations | OR3A3 | 8392 |
| Homo sapiens | Primates | A2a | A2A | ncbigene_synonym | IGKV2D-29 | 28882 |
| Homo sapiens | Primates | C3aR | C3AR | ncbigene_synonym | C3AR1 | 719 |
| Homo sapiens | Primates | Fc&RI | FCRI | ncbigene_synonym | FCGR1A | 2209 |
| Homo sapiens | Primates | Fc&RI | FCRI | ncbigene_synonym | FCGR1BP | 2210 |
| Homo sapiens | Primates | A2 | A2 | ncbigene_synonym | GPR162 | 27239 |
| Homo sapiens | Primates | EP2 | EP2 | ncbigene_synonym | PTGER2 | 5732 |
| Homo sapiens | Primates | EP2 | EP2 | ncbigene_synonym | SPAG11B | 10407 |
| Homo sapiens | Primates | EP3 | EP3 | ncbigene_synonym | PTGER3 | 5733 |
| Homo sapiens | Primates | Btk | BTK | ncbigene_symbol | BTK | 695 |
| Homo sapiens | Primates | PLCY | PLCG | famplex_relations | PLCG1 | 5335 |
| Homo sapiens | Primates | PLCY | PLCG | famplex_relations | PLCG2 | 5336 |
| Homo sapiens | Primates | PLCB | PLCB | famplex_relations | PLCB1 | 23236 |
| Homo sapiens | Primates | PLCB | PLCB | famplex_relations | PLCB2 | 5330 |
| Homo sapiens | Primates | PLCB | PLCB | famplex_relations | PLCB3 | 5331 |
| Homo sapiens | Primates | PLCB | PLCB | famplex_relations | PLCB4 | 5332 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR1A | 5573 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR1B | 5575 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR2A | 5576 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR2B | 5577 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACA | 5566 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACB | 5567 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACG | 5568 |
| Homo sapiens | Primates | OPO, | OPO | ncbigene_synonym | OFCC1 | 266553 |
| Homo sapiens | Primates | PKC | PKC | ncbigene_synonym | PRRT2 | 112476 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCA | 5578 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCB | 5579 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCD | 5580 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCE | 5581 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCG | 5582 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCH | 5583 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCI | 5584 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCQ | 5588 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCZ | 5590 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKD3 | 23683 |
| Homo sapiens | Primates | Lyn | LYN | ncbigene_symbol | LYN | 4067 |
| Homo sapiens | Primates | Syk | SYK | ncbigene_symbol | SYK | 6850 |
| Homo sapiens | Primates | Fyn | FYN | ncbigene_symbol | FYN | 2534 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | NA |